2022
TCT-164 Targeted Therapy With a Localized Abluminal Groove Low-Dose Sirolimus-Eluting Biodegradable-Polymer Coronary Stent: Subgroup Analysis of 5-Year Outcomes of the TARGET All Comers Randomized Trial
Kelbæk H, Lansky A, Xu B, Baumbach A, van Royen N, Knaapen P, Johnson T, Smits P, Vlachojannis G, Arkenbout K, Holmvang L, Janssens L, Ochala A, Wijns W. TCT-164 Targeted Therapy With a Localized Abluminal Groove Low-Dose Sirolimus-Eluting Biodegradable-Polymer Coronary Stent: Subgroup Analysis of 5-Year Outcomes of the TARGET All Comers Randomized Trial. Journal Of The American College Of Cardiology 2022, 80: b66. DOI: 10.1016/j.jacc.2022.08.193.Peer-Reviewed Original Research
2020
The Firehawk Stent: A Review of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent.
Saito Y, Grubman D, Cristea E, Lansky A. The Firehawk Stent: A Review of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent. Cardiology In Review 2020, 28: 208-212. PMID: 32032131, DOI: 10.1097/crd.0000000000000298.Peer-Reviewed Original ResearchConceptsAbluminal grooveFIREHAWK stentBiodegradable Polymer Sirolimus-Eluting StentLate adverse eventsPercutaneous coronary interventionCurrent clinical evidenceSirolimus-Eluting StentsDrug-eluting stent technologyAdverse eventsCoronary interventionClinical outcomesChronic inflammationClinical evidenceHypersensitivity reactionsRecent trialsDrug concentrationsStent technologyStentsInflammationFIREHAWKReviewSirolimus
2017
TCT-806 12-Month Angiographic and Clinical Follow up of the Fantom Sirolimus-eluting Bioresorbable Scaffold
Bouras G, Abizaid A, Carrie D, Frey N, Lutz M, Weber-Albers J, Dudek D, Chevalier B, Cristea E, Lansky A. TCT-806 12-Month Angiographic and Clinical Follow up of the Fantom Sirolimus-eluting Bioresorbable Scaffold. Journal Of The American College Of Cardiology 2017, 70: b328. DOI: 10.1016/j.jacc.2017.09.1016.Peer-Reviewed Original Research
2016
INITIAL RESULTS OF THE FANTOM 1 TRIAL: A FIRST-IN-MAN EVALUATION OF A NOVEL, RADIOPAQUE SIROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD
de Ribamar Costa J, Abizaid A, Chamie D, Lansky A, Kochman J, Koltowski L. INITIAL RESULTS OF THE FANTOM 1 TRIAL: A FIRST-IN-MAN EVALUATION OF A NOVEL, RADIOPAQUE SIROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD. Journal Of The American College Of Cardiology 2016, 67: 232. DOI: 10.1016/s0735-1097(16)30233-9.Peer-Reviewed Original Research
2014
TCT-597 Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials
Ormiston J, Lansky A, Donohoe D, Knape C, Vrolix M, Verheye S, Schoors D, Wijns W. TCT-597 Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials. Journal Of The American College Of Cardiology 2014, 64: b174. DOI: 10.1016/j.jacc.2014.07.661.Peer-Reviewed Original Research